Tranexamic acid

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Tranexamic acid and local guidelines before prescribing.

Antifibrinolytic

Mechanism

Antifibrinolytic blocking lysine binding sites on plasminogen.

Uses

Haemorrhage in trauma, menorrhagia, post-partum haemorrhage, surgical bleeding.

Dosing

4 more dose entries from the chapters

Side effects

Nausea, diarrhoea, seizures at high doses, thrombotic events.

Interactions

Combined oral contraceptives increase thrombosis risk.

Contraindications and cautions

Active thromboembolism, subarachnoid haemorrhage

Monitoring

Seizures, renal function

Pregnancy and breastfeeding

Acceptable

Renal and hepatic impairment

Reduce dose in renal impairment

Overdose and reversal

Supportive

Special advice

Early administration is critical in trauma; reduce in renal impairment; avoid in active thromboembolic disease.

More from the textbook: uses, cautions and other points
Where it is discussed in the book